HCAQ SEC filings, in plain English
Everything HealthCor Catalio Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 3 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Hyperfine (HYPR), the de-SPAC target of HCAQ, reported Q2 2026 revenue of $3.9M (up 44.8% YoY) with a net loss of $9.3M, and reaffirmed full-year 2026 revenue guidance of $20–22M and cash burn of $26–28M. Why it matters: Cash and equivalents rose to $43.5M as of June 30, 2026 (from $35.1M at YE 2025), driven by $13.6M in net debt proceeds and $11.4M from ATM equity sales, extending runway against ongoing operating losses.
What changed: Hyperfine (formerly HCAQ) filed its Q2 2026 10-Q showing revenue of $3.9M for the quarter (up 45% YoY) and $7.8M for six months (up 62% YoY), while net loss narrowed slightly to $9.3M. The company drew $15M on a new $40M senior secured term loan from Horizon Technology Finance (March 2026) and raised $11.4M net via ATM equity sales through June 30, 2026. Why it matters: The new debt and equity raises provide near-term liquidity (cash of $43.5M at June 30, 2026), but the company still reported a $17.9M six-month operating loss and flagged going-concern risk if revenue doesn't scale or additional funding isn't secured. The $25M undrawn loan tranche and ATM capacity offer potential runway extension, but the effective interest rate of 15.94% and warrant dilution (562,500 shares at $1.20) signal costly capital.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“increase revenue from sales, in the longer term, it could result in a substantial doubt about the Company's ability to continue as a going concern. Management believes the net proceeds from the recent offerings, described under”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“increase revenue from sales, in the longer term, it could result in a substantial doubt about the Company's ability to continue as a going concern. Management believes the net proceeds from the recent offering, described under”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Hyperfine, Inc., the successor to HealthCor Catalio Acquisition Corp., called its 2026 annual meeting for Thursday, May 21, 2026 at 10:00 a.m. Eastern Time, held virtually by live webcast, with directors standing for one-year terms until the 2027 annual meeting. Beneficial ownership is based on 83,464,909 shares of Class A common stock and 15,055,288 shares of Class B common stock issued and outstanding as of March 31, 2026. The proxy recaps that HealthCor domesticated as a Delaware corporation on December 21, 2021 and closed the business combination under an agreement dated July 7, 2021. Why it matters: Class B holders control 15.1 million shares against an 83.5 million Class A float, so founder-side voting power persists but does not dominate - outside holders retain meaningful influence, unusual in this cohort. Annual rather than staggered director terms strengthen that further, since the whole board faces shareholders each year. No trust or redemption right remains from the HealthCor SPAC; the equity now tracks device commercialization alone.
- What changed vs 2025-03-17going concern APPEARED
going-concern doubt, mandate language1 moved · 1 with no prior record of ours
- Going-concern doubt
- not statedstated
- Mandate language
- We are focusing on market expansion and are targeting over 9… · unchanged
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“increase revenue from sales, in the longer term, it could result in a substantial doubt about the Company's ability to continue as a going concern. Management believes the net proceeds from the recent offering described under”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“increase revenue from sales, in the longer term, it could result in a substantial doubt about the Company's ability to continue as a going concern. Management believes the net proceeds from the recent offering described under”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.